Evidence map›Paper›PMID 33532785›Full record

ArticlemedRxiv : the preprint server for health sciences2021

More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.

Sandra Lopez-Leon, Talia Wegman-Ostrosky, Carol Perelman, Rosalinda Sepulveda, Paulina A Rebolledo, Angelica Cuapio, Sonia Villapol

2 registry-linked trialsAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04795557 phase2 / phase3completednot on this map

Effect of ADAPT232 Supplementation on Recovery of Patients in Rehabilitation Period in Long COVID-19: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorSwedish Herbal Institute ABRan2021 to 2021Enrolled100ConditionsCovid19ArmsADAPT-232 oral solution, Placebo oral solution
NCT05587868 unknown statusnot on this mapstarted 2022, after this paper: background citation

Karakteristik Dan Pengaruh Vaksinasi COVID-19 Terhadap Klinis Dan Kualitas Hidup Pasien Long COVID di RSUPN Dr. Cipto Mangunkusumo

TypeobservationalSponsorIndonesia UniversityRan2022 to 2023Enrolled250ConditionsCOVID-19, SARS CoV-2 InfectionArmsCOVID-19 Vaccine
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Clinical presentation and pulmonary function tests in post-acute COVID-19 patients.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sandra Lopez-LeonDrug Development, Novartis Pharmaceuticals, New Jersey, USA.ORCID 0000-0001-7504-3441
Talia Wegman-OstroskyInstituto Nacional de Cancerología, Subdirección de Investigación básica, Ciudad de México, México.ORCID 0000-0002-3207-6697
Carol PerelmanNational Autonomous University of Mexico, SOMEDICyT, RedMPC, México.ORCID 0000-0002-0111-1154
Rosalinda SepulvedaHarvard T.H. Chan School of Public Health Boston, Massachusetts, USA.ORCID 0000-0003-1146-9552
Paulina A RebolledoDivison of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-9808-063X
Angelica CuapioCenter for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-9451-1914
Sonia VillapolDepartment of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.ORCID 0000-0002-6174-4113

Funding

The role of the gut microbiome in the neuropathology of traumatic brain injuryR21NS106640 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI VILLAPOL, SONIA · 2018 to 2019
$431k
NINDS NIH HHS R21 NS106640
6 · The paper itself

Abstract

COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1

Identifiers

PMID33532785
PMCPMC7852236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.